共 50 条
- [4] Effectiveness of tixagevimab/cilgavimab in reducing SARS-CoV-2 infections, hospitalizations and mortality in inmunocompromised patients MEDICINA CLINICA, 2024, 163 (06): : 275 - 280
- [10] Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases Bone Marrow Transplantation, 2023, 58 : 340 - 342